A disproportionality analysis of FDA adverse event reporting system (FAERS) events for methimazole and propylthiouracil
Sign Up to like & getrecommendations! Published in 2025 at "PLOS One"
DOI: 10.1371/journal.pone.0328889
Abstract: Background Methimazole and propylthiouracil are the most common antithyroid drugs. We assessed the safety signals associated with methimazole and propylthiouracil by data mining the FDA pharmacovigilance database. Methods Data were retrieved from the FAERS database… read more here.
Keywords: methimazole propylthiouracil; adverse events; reporting; analysis ... See more keywords